Results 41 to 50 of about 17,787 (177)
Long‐Term Follow‐Up of Pleuroparenchymal Fibroelastosis Associated With Crohn's Disease
Secondary PPFE has been reported in association with various underlying conditions, including post‐transplantation and collagen vascular diseases, and cases related to inflammatory bowel disease (IBD) have also been described. Here, we report a rare case of PPFE that developed in the setting of Crohn's disease, a condition with only limited reports in ...
Yuhei Suzuki +11 more
wiley +1 more source
ДИФЕРЕНЦИРАНЕ НА ВИДОВЕ МИКОБАКТЕРИИ ОТ MYCOBACTERIUM AVIUM COMPLEX
Mycobacterium avium complex (МАС) включва M. avium, M. paratuberculosis, M. lepraemurium и M. intracellulare. Mycobacterium avium subsp. avium (МАА) и М. avium subsp.
Таня Савова +3 more
doaj
Kriti Pathak,1,* Stephanie Hart,1,* Leah Lande1,2 1Division of Pulmonary and Critical Care Medicine, Lankenau Medical Center, Wynnewood, PA, USA; 2Lankenau Institute for Medical Research, Wynnewood, PA, USA*These authors contributed equally ...
Pathak K, Hart S, Lande L
doaj
Background/Purpose: Treatment success rates for Mycobacterium avium complex (MAC) diseases range from 50% to 55% only. To explore effective antimicrobials against either Mycobacterium intracellulare or M.
Chen-Cheng Huang +3 more
doaj +1 more source
Histological and Immunohistochemical Characterization of a Histiocytic Sarcoma Associated with a Follicular Lymphoma in a Ring‐tailed Lemur (Lemur catta). Nicolás Aradilla, Rocío Canales, Teresa Lorenzo‐Bermejo, Mireia Mainez, Jordi Aguiló‐Gisbert, David Marbella, Javier María De Pablo‐Moreno and Antonio Rodríguez‐Bertos.
Nicolás Aradilla +7 more
wiley +1 more source
Mycobacterium chimaera: a case report from Italy
Mycobacterium chimaera is an environmental non-tuberculous mycobacterium belonging to Mycobacterium avium complex (MAC). It has been widely known to be associated with disseminated infection after cardiac surgery, related to heater-cooler units used ...
Martina Maria Seminara +3 more
doaj +1 more source
Mycobacterium avium complex (MAC) is a major cause of non-tuberculous pulmonary and disseminated diseases worldwide, inducing bronchiectasis, and affects HIV and immunocompromised patients. In MAC, Mycobacterium avium subsp.
Reaz Uddin +5 more
doaj +1 more source
Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments
ABSTRACT Biofilms formed by mycobacteria, particularly Mycobacterium tuberculosis (Mtb), represent a major challenge in tuberculosis (TB) treatment due to their highly organized structure and their capacity to induce phenotypic drug tolerance. These three‐dimensional bacterial aggregates are embedded in a self‐produced extracellular matrix that ...
Lourdes Serrano Garcia +3 more
wiley +1 more source
Lung organoids as a human system for Mycobacteria infection modeling and drug testing
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza +4 more
wiley +1 more source
Treatment for Mycobacterium avium complex lung disease
Mycobacterium avium complex (MAC) is the major pathologic nontuberculous mycobacteria causing lung disease (LD) in humans worldwide. Although the burden of MAC-LD has increased over the past two decades, treatment remains difficult because of intolerance
Sheng-Wei Pan +3 more
doaj +1 more source

